Personalized Melanoma Vaccine Shows Promise in Preventing Cancer’s Return

Personalized melanoma vaccine shows promise in preventing cancer’s return

A new mRNA-based treatment tailored to each patient's tumor, combined with Keytruda, could help stop deadly melanoma from spreading, a study shows.

Vaccine trial is 'very promising' for cancer patients

SIOUX FALLS, S.D. (KELO) — A vaccine trial is showing promising results in treating skin cancer. Doctors at Sanford Health are researching and testing a new vaccine from Merck and Moderna that could prevent the recurrence of melanoma, a type of skin cancer. "It actually takes those melanoma cells, profiles it, looks at the genetics [...]

Moderna’s personalized mRNA shot could reshape the fight against skin cancer — but it may also be overhyped

Doctors and patients are excited about the possible breakthrough, but some analysts believe there’s too much hype.

Doctors explain how Moderna's melanoma mRNA vaccine could fight deadliest form of skin cancer

CBS News medical correspondent Dr. Céline Gounder, who has had melanoma herself, said Moderna's experimental trial is "a big win for mRNA vaccines against cancer."